03/11/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
7:02 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
6:03 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/08/2024
4:38 PM | Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Boor Kathryn Jean (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:00 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:34 PM | Mayo Stephen (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
6:55 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
6:42 PM | Estepan Ian Michael (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
3:47 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
12:34 PM | JANUS HENDERSON GROUP PLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/26/2024
4:26 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A | |
01/08/2024
11:08 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
7:00 PM | Arif Bilal (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:00 PM | Rodino-Klapac Louise (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:00 AM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:00 AM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2023
7:00 AM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
7:00 AM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
7:00 AM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:40 AM | Chambers Michael Andrew (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2023
7:00 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/04/2023
5:25 PM | Sarepta Therapeutics (Subject)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Pentagon contract could send this $2 AI stock soaring (Ad) Whenever the Department of Defense awards a major AI contract...
Early investors could see dramatic returns virtually overnight.
That's how my readers were able to cash in gains like 133% in just four months on C3.ai... Get all the info here >>> |
08/02/2023
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
3:49 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
1:22 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
7:00 PM | Brown Ryan Edward (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2023
3:08 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A | |
04/24/2023
3:10 PM | Sarepta Therapeutics (Filer)
| Form ARS | |
04/24/2023
3:16 PM | Sarepta Therapeutics (Filer)
| Form DEFA14A | |
